DK135505B - Analogifremgangsmåde til fremstilling af morpholinderivater. - Google Patents

Analogifremgangsmåde til fremstilling af morpholinderivater.

Info

Publication number
DK135505B
DK135505B DK433473AA DK433473A DK135505B DK 135505 B DK135505 B DK 135505B DK 433473A A DK433473A A DK 433473AA DK 433473 A DK433473 A DK 433473A DK 135505 B DK135505 B DK 135505B
Authority
DK
Denmark
Prior art keywords
preparation
analogous process
morpholine derivatives
morpholine
derivatives
Prior art date
Application number
DK433473AA
Other languages
Danish (da)
English (en)
Other versions
DK135505C (tr
Inventor
Edwin Harry Paterson Young
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of DK135505B publication Critical patent/DK135505B/da
Application granted granted Critical
Publication of DK135505C publication Critical patent/DK135505C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/36Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK433473AA 1972-08-11 1973-08-07 Analogifremgangsmåde til fremstilling af morpholinderivater. DK135505B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3755072A GB1382526A (en) 1972-08-11 1972-08-11 Morpholine derivatives

Publications (2)

Publication Number Publication Date
DK135505B true DK135505B (da) 1977-05-09
DK135505C DK135505C (tr) 1977-10-17

Family

ID=10397311

Family Applications (1)

Application Number Title Priority Date Filing Date
DK433473AA DK135505B (da) 1972-08-11 1973-08-07 Analogifremgangsmåde til fremstilling af morpholinderivater.

Country Status (22)

Country Link
US (2) US3974158A (tr)
JP (2) JPS572710B2 (tr)
AT (8) AT327930B (tr)
AU (2) AU468101B2 (tr)
BE (2) BE803283A (tr)
CH (4) CH594645A5 (tr)
CS (4) CS183681B2 (tr)
DD (2) DD108299A5 (tr)
DE (2) DE2340873A1 (tr)
DK (1) DK135505B (tr)
ES (1) ES417796A1 (tr)
FR (2) FR2195454B1 (tr)
GB (1) GB1382526A (tr)
HU (2) HU167000B (tr)
IE (1) IE37928B1 (tr)
IL (2) IL42841A (tr)
IN (1) IN137769B (tr)
NL (2) NL7311068A (tr)
PL (4) PL91729B1 (tr)
SE (1) SE385889B (tr)
SU (7) SU503521A3 (tr)
ZA (2) ZA735007B (tr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1064927A (en) * 1975-01-29 1979-10-23 Yuji Kawashima Process of producing 2-(indenyloxymethyl) morpholine derivatives
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB2184438B (en) * 1985-12-19 1990-10-03 Ici Plc Heterocyclic compounds
GB8827152D0 (en) * 1988-11-21 1988-12-29 Wellcome Found Anti-atherosclerotic diaryl compounds
US5290814A (en) * 1988-11-21 1994-03-01 Burroughs Wellcome Co. Anti-atherosclerotic diaryl compounds
EP0507488A1 (en) * 1991-03-27 1992-10-07 Merck & Co. Inc. Inhibitors of HIV-1 reverse transcriptase
WO1993015052A1 (en) * 1992-01-28 1993-08-05 Smithkline Beecham Plc Compounds as calcium channel antagonists
WO1998007710A1 (en) * 1996-08-23 1998-02-26 Neurosearch A/S Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine d4 receptor antagonists
EP1187810A2 (en) * 1999-05-25 2002-03-20 Sepracor, Inc. Heterocyclic analgesic compounds and their use
US7361666B2 (en) 1999-05-25 2008-04-22 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
US6677332B1 (en) 1999-05-25 2004-01-13 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
US6635661B2 (en) 2000-05-25 2003-10-21 Sepracor Inc. Heterocyclic analgesic compounds and methods of use thereof
AU2001216218A1 (en) 2000-05-25 2001-12-11 Sepracor, Inc. Heterocyclic analgesic compounds and method of use thereof
WO2002022572A2 (en) 2000-09-11 2002-03-21 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
WO2006001326A1 (ja) * 2004-06-24 2006-01-05 Sankyo Company, Limited N-カルボニル飽和複素環類の製造方法及びその合成中間体
TWI452044B (zh) * 2007-06-15 2014-09-11 Mitsubishi Tanabe Pharma Corp 嗎啉衍生物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH386443A (de) * 1959-12-16 1965-01-15 Geigy Ag J R Verfahren zur Herstellung von neuen tetrasubstituierten Alkylendiaminen
GB1138405A (en) * 1966-12-28 1969-01-01 Ici Ltd Morpholine derivatives

Also Published As

Publication number Publication date
BE803283A (fr) 1974-02-06
ATA701673A (de) 1975-06-15
ZA735008B (en) 1974-06-26
CS182799B2 (en) 1978-05-31
US3974158A (en) 1976-08-10
JPS572710B2 (tr) 1982-01-18
SU508200A3 (ru) 1976-03-25
ATA975074A (de) 1975-05-15
AU5849173A (en) 1975-01-30
AT327931B (de) 1976-02-25
CS182798B2 (en) 1978-05-31
FR2195448B1 (tr) 1977-02-25
HU166870B (tr) 1975-06-28
DD108299A5 (tr) 1974-09-12
ATA925074A (de) 1975-04-15
DK135505C (tr) 1977-10-17
FR2195448A1 (tr) 1974-03-08
IL42841A (en) 1976-04-30
AT327930B (de) 1976-02-25
PL95166B1 (tr) 1977-09-30
PL90322B1 (tr) 1977-01-31
SU503521A3 (ru) 1976-02-15
CS182790B2 (en) 1978-05-31
SU509231A3 (ru) 1976-03-30
AT327210B (de) 1976-01-26
IL42842A0 (en) 1973-10-25
PL91728B1 (tr) 1977-03-31
SE385889B (sv) 1976-07-26
AT327932B (de) 1976-02-25
CH594646A5 (tr) 1978-01-13
DE2340874A1 (de) 1974-02-21
AT326675B (de) 1975-12-29
AU5848573A (en) 1975-01-30
SU508199A3 (ru) 1976-03-25
CH594645A5 (tr) 1978-01-13
AT327929B (de) 1976-02-25
DD107931A5 (tr) 1974-08-20
NL7311068A (tr) 1974-02-13
AU468101B2 (en) 1975-12-18
BE803284A (fr) 1974-02-06
SU508201A3 (ru) 1976-03-25
IE37928L (en) 1974-02-11
FR2195454B1 (tr) 1977-02-25
NL7311069A (tr) 1974-02-13
DE2340873A1 (de) 1974-02-28
CS183681B2 (en) 1978-07-31
IN137769B (tr) 1975-09-13
AU471402B2 (en) 1976-04-29
FR2195454A1 (tr) 1974-03-08
ATA974874A (de) 1975-05-15
CH594644A5 (tr) 1978-01-13
ZA735007B (en) 1974-06-26
ATA924974A (de) 1975-03-15
AT328460B (de) 1976-03-25
IL42841A0 (en) 1973-10-25
SU537627A3 (ru) 1976-11-30
JPS5046675A (tr) 1975-04-25
ATA701773A (de) 1975-05-15
IE37928B1 (en) 1977-11-09
CH594642A5 (tr) 1978-01-13
HU167000B (tr) 1975-07-28
PL91729B1 (tr) 1977-03-31
JPS49124079A (tr) 1974-11-27
US3974156A (en) 1976-08-10
ATA974974A (de) 1975-05-15
GB1382526A (en) 1975-02-05
ES417796A1 (es) 1976-02-16
SU521844A3 (ru) 1976-07-15

Similar Documents

Publication Publication Date Title
DK137329B (da) Analogifremgangsmåde til fremstilling af 2-karbalkoksyaminobenzimidazolderivater.
DK134607B (da) Fremgangsmåde til fremstilling af rapamycin.
DK140340B (da) Analogifremgangsmåde til fremstilling af benzoxazolderivater.
DK135505B (da) Analogifremgangsmåde til fremstilling af morpholinderivater.
DK136312B (da) Analogifremgangsmåde til fremstilling af substituerede piperidinoalkanonoximderivater.
DK138492B (da) Fremgangsmåde til fremstilling af morphinanderivater.
DK134490B (da) Analogifremgangsmåde til fremstilling af 2,6-diaminonebularin-derivater.
DK135991B (da) Analogifremgangsmåde til fremstilling af 2-oxazolinderivater.
DK136360B (da) Analogifremgangsmåde til fremstilling af isoindolinderivater.
DK125800B (da) Analogifremgangsmåde til fremstilling af morpholinderivater.
DK138317B (da) Analogifremgangsmåde til fremstilling af cyklohexenonderivater.
DK134604B (da) Fremgangsmåde til fremstilling af indenyl-3-acetoglucuronider.
DK138796B (da) Analogifremgangsmåde til fremstilling af 2-carboxypyrazin-4-oxidderivater.
DK138230B (da) Analogifremgangsmåde til fremstilling af vincanolsalte.
DK140668B (da) Analogifremgangsmåde til fremstilling af kondenserede pyriminderivater.
DK131864B (da) Fremgangsmåde til fremstilling af pregnan-21-syrederivater.
FI52735C (fi) Menetelmä uusien pregnadieeni-21-happojohdannaisten valmistamiseksi.
DK135122B (da) Analogifremgangsmåde til fremstilling af 4-aryl-5-aminoalkyl-4-oxazolin-2-onderivater.
DK135685B (da) Analogifremgangsmåde til fremstilling af morfolinderivater.
DK132430B (da) Fremgangsmåde til fremstilling af quinazolinonderivater.
DK131575B (da) Analogifremgangsmåde til fremstilling af 2beta-hydroxy-3alfa-aminosteroider.
DK138645B (da) Analogifremgangsmåde til fremstilling af sulfamoylfenyl-imidazolidiner.
DK133667B (da) Fremgangsmåde til fremstilling af 5-cyklohexyl-6-halogenindan-1-karboxylsyrederivater.
DK136361B (da) Fremgangsmåde til fremstilling af quinolin-derivater.
DK129657B (da) Analogifremgangsmåde til fremstilling af 3-methylpyrazol-5-carboxamider.